Javascript is required for this site to function correctly.
Please enable Javascript support.

News & Events Archive

Here you'll find current articles and information about Parkinson's and the Foundation, as well as information about events the Foundation is sponsoring. You can also view the Foundation's public service announcements featuring Michael J. Fox.

The latest on PD, as reported by major news outlets.

10/18/2011 Panel: Teva's Azilect Data Close, but No Cigar for Parkinson's Delay Claim

Scrip - FDA advisory committee rules that Teva's Azilect does not provide substantial evidence for modification of clinical progression of Parkinson's.

10/03/2011 A New (Old) Treatment Option for Depression in Parkinson's Disease

The American Journal of Psychiatry -
Roseanne D. Dobkin, Ph.D. and colleagues report randomized controlled trial of cognitive-behavioral therapy adapted especially for depression in Parkinson’s disease.

09/29/2011 Beer, Liquor May Have Opposite Effects on PD Risk

Medscape - Medscape reports that moderate beer drinking may lower PD risk while consuming liquor may raise it.

Access the latest articles in the media about Michael J. Fox.

11/13/2011 Michael J. Fox Performs Johnny B. Goode at MJFF's Annual Gala

Michael J. Fox revived his Back to the Future days with a live performance of Johnny B. Goode at MJFF's Annual Gala, A Funny Thing Happened on the Way to Cure Parkinson's.

11/09/2011 Congrats to Michael J. Fox for His 2012 People's Choice Award Nomination!

Michael J. Fox is nominated in the "Favorite TV Guest Star" category for his role as Louis Canning on The Good Wife.

07/14/2011 The Foundation congratulates Michael J. Fox on his Emmy nomination!

Michael J. Fox is nominated for a Primetime Emmy for his guest role as Louis Canning in The Good Wife.

Browse current and past press releases from The Michael J. Fox Foundation.

05/01/2012 Michael J. Fox Foundation-funded Study Identifies Best Clinical Rating Scale

Investigator ‘hopeful that the Unified Dyskinesia Rating Scale will be a useful tool to help translate research into treatments’

04/24/2012 Fox Trial Finder, Web-Based Clinical Trial Matcher to Accelerate Parkinson's Research, Launched by Michael J. Fox Foundation

 
 

04/19/2012 Sanofi and Michael J. Fox Foundation Collaborate on Potential New Treatment for Parkinson's Disease

 Fox Foundation to sponsor a clinical trial to study Sanofi compound 

Read announcements and articles about what's new at the Foundation.

04/20/2012 Sanofi Taps Fox Foundation For Parkinson's Drug Development

The Pink Sheet Daily -

12/08/2011 Michael J. Fox Calls on Parkinson's Patients, Community to Join "Fox Trial Finder” in New Issue of Neurology Now

American Academy of Neurology - Michael J. Fox is calling on people with Parkinson’s and those without the disease to join Fox Trial Finder, a new web tool that connects volunteers with clinical trials that desperately need participants for the testing of new drugs and other treatments.

12/02/2011 MJFF Announces New Awards for October

The Foundation completed contracting on awards totaling more than $5 million, in targeted funding to speed breakthroughs that can lead to new and better treatments for PD.

See the public service announcements featuring Michael J. Fox that are helping to get the word out about the importance of stopping Parkinson's.

03/27/2012 A Patient-centric Approach

MJFF Co-Founder and Executive Vice Chairman Debi Brooks talks with Dave Iverson on evolution of the Foundation’s patient-centric approach, and how the Parkinson’s community can get involved today.

03/05/2012 Improving the Delivery of Levodopa

MJFF CEO Todd Sherer discusses approaches aimed at limiting the on-off fluctuations associated with the symptomatic treatments of PD.

03/05/2012 A Personalized Approach to Treating PD

MJFF's first on staff MD Maurizio Facheris discusses why understanding the connection between genetics and environmental factors could one day lead to a personalized approach to treating PD.

The Foundation welcomes journalists' inquiries on Foundation-funded research as well as developments in Parkinson's science.
Learn More